Skip to main content

Table 1 Patient characteristics in the successful and failed conversion surgery groups

From: The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study

 

SC group (n = 12)

FC group (n = 38)

P value

Gender (male)

11 (91.7%)

21 (55.3%)

0.02

Age

69.7 (±3.2)

68.6 (±1.8)

0.78

BMI

21.9 (±1.3)

20.9 (±0.7)

0.53

White blood cell (/μl)

6593 (±473)

6047 (±266)

0.32

NLR

2.4 (±0.6)

4.4 (±0.4)

0.008

Hemoglobin (g/dl)

11.2 (±0.4)

11.4 (±0.6)

0.79

Platelet count (× 104/μl)

31.3 (±3.6)

30.4 (±1.9)

0.81

CRP (mg/dl)

0.8 (±0.7)

1.3 (±0.4)

0.53

Total protein (g/dl)

6.8 (±0.2)

6.6 (±0.1)

0.38

Albumin (g/dl)

3.8 (±0.2)

3.4 (±0.1)

0.04

Cholinesterase (U/l)

230 (±27)

212 (±15)

0.55

CEA (<  5 ng/ml)

9 (75.0%)

20 (52.6%)

0.17

CA19–9 (<  37 U/ml)

10 (83.3%)

21 (55.3%)

0.08

CA125 (<  35 U/ml)

10 (83.3%)

34 (72.7%)

0.46

  1. Values are in n (%) or mean (± standard deviation)
  2. Abbreviations: BMI Body mass index, NLR neutrophil/lymphocyte ratio, CRP C-reactive protein, CEA carcinoembryonic antigen, CA 19–9 carbohydrate antigen 19–9, CA 125 carbohydrate antigen 125